Glenmede Trust’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,674
| Closed | -$87K | – | 2561 |
|
|
2020
Q3 | $87K | Sell |
1,674
-4,336
| -72% | -$225K | ﹤0.01% | 1210 |
|
|
2020
Q2 | $199K | Buy |
6,010
+5,149
| +598% | +$170K | ﹤0.01% | 1014 |
|
|
2020
Q1 | $16K | Hold |
861
| – | – | ﹤0.01% | 2207 |
|
|
2019
Q4 | $16K | Buy |
861
+140
| +19% | +$2.6K | ﹤0.01% | 2207 |
|
|
2019
Q3 | $9 | Buy |
721
+359
| +99% | +$4 | ﹤0.01% | 2417 |
|
|
2019
Q2 | $4 | Hold |
362
| – | – | ﹤0.01% | 2714 |
|
|
2019
Q1 | $5 | Sell |
362
-73
| -17% | -$1 | ﹤0.01% | 2635 |
|
|
2018
Q4 | $4 | Buy |
+435
| New | +$4 | ﹤0.01% | 2630 |
|
|
2018
Q2 | – | Sell |
-618
| Closed | -$8K | – | 2444 |
|
|
2018
Q1 | $8K | Hold |
618
| – | – | ﹤0.01% | 2271 |
|
|
2017
Q4 | $8K | Sell |
618
-14,340
| -96% | -$186K | ﹤0.01% | 2271 |
|
|
2017
Q3 | $276K | Sell |
14,958
-26,921
| -64% | -$497K | ﹤0.01% | 1111 |
|
|
2017
Q2 | $559K | Hold |
41,879
| – | – | ﹤0.01% | 914 |
|
|
2017
Q1 | $559K | Buy |
+41,879
| New | +$559K | ﹤0.01% | 914 |
|
|
2016
Q3 | – | Sell |
-119
| Closed | -$1K | – | 2715 |
|
|
2016
Q2 | $1K | Sell |
119
-23,284
| -99% | -$196K | ﹤0.01% | 2502 |
|
|
2016
Q1 | $216K | Buy |
23,403
+119
| +0.5% | +$1.1K | ﹤0.01% | 1141 |
|
|
2015
Q4 | $345K | Hold |
23,284
| – | – | ﹤0.01% | 1036 |
|
|
2015
Q3 | $382K | Buy |
+23,284
| New | +$382K | ﹤0.01% | 1007 |
|
|
2013
Q3 | – | Sell |
-1,425
| Closed | -$21K | – | 2293 |
|
|
2013
Q2 | $21K | Buy |
+1,425
| New | +$21K | ﹤0.01% | 1715 |
|